• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 型与宿主免疫应答。

SARS-CoV-2 and the host-immune response.

机构信息

Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States.

Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States.

出版信息

Front Immunol. 2023 Jun 19;14:1195871. doi: 10.3389/fimmu.2023.1195871. eCollection 2023.

DOI:10.3389/fimmu.2023.1195871
PMID:37404823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10315470/
Abstract

The SARS-CoV-2 pandemic and the COVID-19 disease have affected everyone globally, leading to one of recorded history's most significant research surges. As our knowledge evolves, our approaches to the virus and treatments must also evolve. The evaluation of future research approaches to SARS-CoV-2 will necessitate reviewing the host immune response and viral antagonism of that response. This review provides an overview of the current knowledge on SARS-CoV-2 by summarizing the virus and human response. The focuses are on the viral genome, replication cycle, host immune activation, response, signaling, and antagonism. To effectively fight the pandemic, efforts must focus on the current state of research to help develop treatments and prepare for future outbreaks.

摘要

SARS-CoV-2 大流行和 COVID-19 疾病已在全球范围内影响到每个人,导致了有记录以来规模最大的研究热潮之一。随着我们知识的不断发展,我们对病毒的处理方法和治疗方法也必须随之发展。评估未来针对 SARS-CoV-2 的研究方法需要对宿主免疫反应和病毒对该反应的拮抗作用进行审查。这篇综述通过总结病毒和人类反应,提供了 SARS-CoV-2 的最新知识概述。重点介绍了病毒基因组、复制周期、宿主免疫激活、反应、信号转导和拮抗作用。为了有效抗击大流行,必须集中精力研究当前的研究状况,以帮助开发治疗方法并为未来的疫情爆发做好准备。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dac/10315470/746334a24815/fimmu-14-1195871-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dac/10315470/b616817b808e/fimmu-14-1195871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dac/10315470/746334a24815/fimmu-14-1195871-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dac/10315470/b616817b808e/fimmu-14-1195871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dac/10315470/746334a24815/fimmu-14-1195871-g002.jpg

相似文献

1
SARS-CoV-2 and the host-immune response.严重急性呼吸综合征冠状病毒 2 型与宿主免疫应答。
Front Immunol. 2023 Jun 19;14:1195871. doi: 10.3389/fimmu.2023.1195871. eCollection 2023.
2
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。
Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.
3
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.宿主与 SARS-CoV-2 的较量:固有免疫与病毒逃逸策略。
Mol Ther. 2022 May 4;30(5):1869-1884. doi: 10.1016/j.ymthe.2022.02.014. Epub 2022 Feb 14.
4
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.SARS-CoV-2 与 COVID-19 免疫病理的免疫反应——当前观点。
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
5
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.SARS-CoV-2 感染期间的固有免疫:逃逸策略和激活触发缺氧和血管损伤。
Clin Exp Immunol. 2020 Nov;202(2):193-209. doi: 10.1111/cei.13523. Epub 2020 Oct 12.
6
[Interaction between SARS-CoV-2 and Host Innate Immunity].[严重急性呼吸综合征冠状病毒2与宿主固有免疫之间的相互作用]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Jan;53(1):1-6. doi: 10.12182/20220160101.
7
The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2.宿主免疫反应在精细调控 SARS-CoV-2 感染和疫苗开发中的关键作用。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3297-3309. doi: 10.1080/21645515.2021.1935172. Epub 2021 Jun 11.
8
Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.严重急性呼吸综合征冠状病毒 2 型对 I 型干扰素的拮抗作用。
J Interferon Cytokine Res. 2020 Dec;40(12):543-548. doi: 10.1089/jir.2020.0214.
9
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.SARS-CoV-2 非结构蛋白及其在宿主免疫逃逸中的作用。
Viruses. 2022 Sep 8;14(9):1991. doi: 10.3390/v14091991.
10
SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.SARS-CoV-2 介导的抗病毒干扰素途径的逃逸策略。
J Microbiol. 2022 Mar;60(3):290-299. doi: 10.1007/s12275-022-1525-1. Epub 2022 Feb 5.

引用本文的文献

1
Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节
Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.
2
Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru.秘鲁住院的未接种疫苗的新冠肺炎患者体内抗新冠病毒 2 型抗体的动力学及血液学参数
PeerJ. 2025 Aug 22;13:e19771. doi: 10.7717/peerj.19771. eCollection 2025.
3
Peripheral immune progression to long COVID is associated with mitochondrial gene transcription: A meta-analysis.

本文引用的文献

1
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq.利用Perturb-seq对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宿主因子进行系统功能研究。
Nat Commun. 2023 Oct 6;14(1):6245. doi: 10.1038/s41467-023-41788-4.
2
SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development.严重急性呼吸综合征冠状病毒 2 型 E 蛋白:发病机制与潜在治疗开发。
Biomed Pharmacother. 2023 Mar;159:114242. doi: 10.1016/j.biopha.2023.114242. Epub 2023 Jan 11.
3
Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines.
外周免疫进展为长期新冠与线粒体基因转录相关:一项荟萃分析。
Mitochondrion. 2025 Jul 28;85:102072. doi: 10.1016/j.mito.2025.102072.
4
Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers.探索对SARS-CoV-2的免疫反应:来自一组委内瑞拉混血志愿者中接种国药集团(BBIBP-CorV)疫苗个体的见解。
Biomedicines. 2025 Jun 25;13(7):1550. doi: 10.3390/biomedicines13071550.
5
Understanding the long-term interplay of SARS-CoV-2 immune and inflammatory responses with proteases in COVID-19 recovery: a longitudinal study.了解SARS-CoV-2免疫和炎症反应与蛋白酶在新冠病毒感染康复过程中的长期相互作用:一项纵向研究
Front Immunol. 2025 Jun 10;16:1517933. doi: 10.3389/fimmu.2025.1517933. eCollection 2025.
6
Virus-Induced Pathogenic Antibodies: Lessons from Long COVID and Dengue Hemorrhage Fever.病毒诱导的致病性抗体:来自长期新冠和登革出血热的教训。
Int J Mol Sci. 2025 Feb 22;26(5):1898. doi: 10.3390/ijms26051898.
7
Immune Response Against SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫反应
Vaccines (Basel). 2024 Dec 11;12(12):1390. doi: 10.3390/vaccines12121390.
8
Immune Profile in COVID-19: Unveiling T Cells in SARS-CoV-2 Infection.新型冠状病毒肺炎中的免疫特征:揭示 SARS-CoV-2 感染中的 T 细胞。
Int J Mol Sci. 2024 Sep 28;25(19):10465. doi: 10.3390/ijms251910465.
9
COVID-19-related Pneumonitis in Immunocompromised Patients: Reviewing Clinical Features and Management Approaches.免疫功能低下患者的新型冠状病毒肺炎相关肺炎:临床特征与管理方法综述
J Community Hosp Intern Med Perspect. 2024 Sep 9;14(5):63-72. doi: 10.55729/2000-9666.1399. eCollection 2024.
10
Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections.不同可溶性免疫检查点特征可用于表征 COVID-19 严重程度、死亡率和 SARS-CoV-2 变异感染。
Front Immunol. 2024 Sep 23;15:1464480. doi: 10.3389/fimmu.2024.1464480. eCollection 2024.
用于合理设计逻辑下一代疫苗的 SARS-CoV-2 动态出现算法。
Commun Biol. 2022 Oct 10;5(1):1081. doi: 10.1038/s42003-022-04030-3.
4
The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic.武汉华南海鲜批发市场是 COVID-19 疫情的早期震中。
Science. 2022 Aug 26;377(6609):951-959. doi: 10.1126/science.abp8715. Epub 2022 Jul 26.
5
The humoral response and antibodies against SARS-CoV-2 infection.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的体液免疫反应及抗体
Nat Immunol. 2022 Jul;23(7):1008-1020. doi: 10.1038/s41590-022-01248-5. Epub 2022 Jun 27.
6
SARS-CoV-2-specific CD4 T cells are associated with long-term persistence of neutralizing antibodies.SARS-CoV-2 特异性 CD4 T 细胞与中和抗体的长期持久性相关。
Signal Transduct Target Ther. 2022 Apr 23;7(1):132. doi: 10.1038/s41392-022-00978-0.
7
SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白诱导的细胞融合激活了环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白(cGAS-STING)途径和干扰素反应。
Sci Signal. 2022 Apr 12;15(729):eabg8744. doi: 10.1126/scisignal.abg8744.
8
SARS-CoV-2 pathogenesis.严重急性呼吸综合征冠状病毒 2 型的发病机制。
Nat Rev Microbiol. 2022 May;20(5):270-284. doi: 10.1038/s41579-022-00713-0. Epub 2022 Mar 30.
9
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8.SARS-CoV-2 ORF8 对白细胞介素-17A 的病毒模拟。
mBio. 2022 Apr 26;13(2):e0040222. doi: 10.1128/mbio.00402-22. Epub 2022 Mar 28.
10
RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection.RIG-I 诱导的先天性抗病毒免疫保护小鼠免受致死性 SARS-CoV-2 感染。
Mol Ther Nucleic Acids. 2022 Mar 8;27:1225-1234. doi: 10.1016/j.omtn.2022.02.008. Epub 2022 Feb 13.